TAK-020
TAK-020 is a potent, covalent Bruton's tyrosine kinase (Btk) inhibitor for research use. It is employed in preclinical studies to investigate Btk's role in autoimmune and inflammatory diseases, such as rheumatoid arthritis, utilizing both in vitro biochemical assays and in vivo disease models.
Product Specifications
CAS Number
1627603-21-7
Product Name Alternative
BTK, TAK 020, TAK020, TAK-020
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction
Purity
98.66% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.85 mM) ; DMSO:20 mg/mL (56.92 mM)
Smiles
C=CC (=O) N1CC[C@@H] (C1) Oc1nc (cc2ccccc12) -c1nc (=O) [nH][nH]1
Molecular Formula
C18H17N5O3
Molecular Weight
351.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6201909-01 0.1 mL
MRC1 (Macrophage Mannose Receptor 1, MMR, C-type Lectin Domain Family 13 Member D, C-type Lectin Domain Family 13 Member D-like, Macrophage Mannose Receptor 1-like Protein 1, CD206, CLEC13D, CLEC13DL, MRC1L1) (MaxLight 490)
Sign In for Pricing
View Details MBS6201909-02 5x 0.1 mL
MRC1 (Macrophage Mannose Receptor 1, MMR, C-type Lectin Domain Family 13 Member D, C-type Lectin Domain Family 13 Member D-like, Macrophage Mannose Receptor 1-like Protein 1, CD206, CLEC13D, CLEC13DL, MRC1L1) (MaxLight 490)
Sign In for Pricing
View Details 